نتایج جستجو برای: hepatic fibrosis

تعداد نتایج: 195012  

2014
Yang-Lin Liu Helen L. Reeves Alastair D. Burt Dina Tiniakos Stuart McPherson Julian B. S. Leathart Michael E. D. Allison Graeme J. Alexander Anne-Christine Piguet Rodolphe Anty Peter Donaldson Guruprasad P. Aithal Sven Francque Luc Van Gaal Karine Clement Vlad Ratziu Jean-Francois Dufour Christopher P. Day Ann K. Daly Quentin M. Anstee

Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition, strongly associated with the metabolic syndrome, that can lead to progressive hepatic fibrosis, cirrhosis and hepatic failure. Subtle inter-patient genetic variation and environmental factors combine to determine variation in disease progression. A common non-synonymous polymorphism in TM6SF2 (rs58542926 c.449 C>T, p...

Journal: :Gastroenterology 2008
Diarmuid S Manning Nezam H Afdhal

Hepatic fibrosis is the final common pathway for many different liver insults. Originally considered to be irreversible, hepatic fibrosis is now known to be a dynamic process with a significant potential for resolution. The diagnosis and quantitation of fibrosis have traditionally relied on liver biopsy. However, there are a number of drawbacks including the invasive nature of the procedure, sa...

2014
FEI WANG SHUYUAN LIU TAIPING DU HAO CHEN ZHIYONG LI JINGWANG YAN

An effective treatment for hepatic fibrosis is not available clinically. Nuclear factor (NF)-κB plays a central role in inflammation and fibrosis. The aim of the present study was to investigate the effect of an NF-κB inhibitor, BAY-11-7082 (BAY), on mouse liver fibrosis. The effects of BAY on hepatic stellate cell (HSC) activation were measured in the lipopolysaccharide-activated rat HSC-T6 ce...

2016

Excessive hepatic fibrosis leading towards the cirrhosis is the major determinant of morbidity and mortality in chronic liver disease patients. The reversing hepatic fibrosis has been intensively studied and fuelled up the hope in development of effective and targeted antifibrotic therapy in upcoming years. There are four pillars of pharmacological approach in regression of fibrosiscessation of...

2016
Mio Kitano P. Mark Bloomston

microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by either blocking translation or inducing degradation of target mRNA. miRNAs play essential roles in diverse biological and pathological processes, including development of hepatic fibrosis. Hepatic stellate cells (HSCs) play a central role in development of hepatic fibrosis and there are intricate regulatory effects of...

2009
Y. Wang F. H. Miller R. McCarthy Z. Chen L. Sternick D. Ganger R. Ehman R. Omary J. Levitsky L. Merrick B. D. Bolster S. Shah S. Zuehlsdorff V. Yaghmai P. Nikolaidis

INTRODUCTION: Hepatic fibrosis is a wound-healing response to multiple types of chronic liver disease or injury. Cirrhosis, the end-stage of liver fibrosis, is a major cause of death due to its association with hepatocellular carcinoma and complicated portal hypertension. Accurate discrimination of advanced fibrosis and cirrhosis from mild fibrosis in patients with chronic liver disease is esse...

Journal: :hepatitis monthly 0
baris yilmaz department of gastroenterology, diskapi yildirim beyazit education and research hospital, ankara, turkey; department of gastroenterology, diskapi yildirim beyazit education and research hospital, ankara, turkey. tel: +90-3125963085, fax: +90-3123186690 bora aktas department of gastroenterology, diskapi yildirim beyazit education and research hospital, ankara, turkey akif altinbas department of gastroenterology, diskapi yildirim beyazit education and research hospital, ankara, turkey zeynep ginis department of biochemistry, diskapi yildirim beyazit education and research hospital, ankara, turkey gulfer ozturk department of biochemistry, diskapi yildirim beyazit education and research hospital, ankara, turkey fuat ekiz department of gastroenterology, diskapi yildirim beyazit education and research hospital, ankara, turkey

conclusions m30 levels were higher in cvhb patients compared to healthy controls. however, m30 levels were similar in the mild and moderate stages of fibrosis, so they did not indicate the severity of underlying fibrotic or inflammatory processes in cvhb patients. results the mean ages of patients and controls were 39.7 and 45.7 years, respectively, and 35% of the controls and 52% of the patien...

2012
Yi-Lin Yang Li Di Yun-You Duan Xi Liu Jie Liu Rui-Jing Yang Sheng Chen Li-Jun Yuan

BACKGROUND Progressive hepatic fibrosis is the eventual cause of liver cirrhosis. Doppler ultrasound has been used to detect hemodynamic changes that are known to be present during the pre-cirrhotic stages of hepatic fibrogenesis. However, the relationship between the Doppler ultrasound parameters and the impairment of the liver function has not been fully investigated. The purpose of this stud...

2010
Michelle DallaPiazza Valerianna K. Amorosa Russell Localio Jay R. Kostman Vincent Lo Re

Background: HIV-monoinfected patients may be at risk for significant liver fibrosis, but its prevalence and determinants in these patients are unknown. Since HIV-monoinfected patients do not routinely undergo liver biopsy, we evaluated the prevalence and risk factors of significant hepatic fibrosis in this group using the aspartate aminotransferase (AST)-to-platelet ratio index (APRI). Methods:...

Journal: :QJM : monthly journal of the Association of Physicians 2012
P Ramachandran J P Iredale

Liver fibrosis is the generic response to chronic injury of varying aetiologies. A number of common mechanisms link this response to the pathogenesis of fibrosis in other organs. While long thought to be relentlessly progressive, there is now excellent evidence in both human liver disease and animal models that hepatic fibrosis is potentially reversible. The liver therefore provides an excellen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید